Please Wait...

Molecular Marker Lab

Specialized biomarker services backed by unrivalled scientific expertise, fully validated technology and the highest quality standard.

Molecular Marker Lab - Highly Specialized Biomarker Services for Clinical Trials

Bioclinica Lab is a highly specialized service provider of biochemical marker analysis to the pharmaceutical and biotech industries. Our extensive panel of validated biomarkers serve as surrogate endpoints in support of global, multi-site, clinical trials – from phase I to IV – across a wide range of therapeutic areas. With over 15 years of experience, over 400 clinical trials supported, and over 1 million samples analyzed, we are committed to providing quality services for your clinical study.

BIOMARKER MENU

View our complete list of validated Biomarker assays.
LEARN MORE

BIOMARKER ANALYSIS

Automated methods for Biomarker detection and analysis.
LEARN MORE

CLINICAL LAB SERVICES

In house scientific and technical expertise.
LEARN MORE

QUALITY ASSURANCE

Rigorous QA and CAP accreditation.
LEARN MORE

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

A great resource for Alzheimers's research teams. https://t.co/qhVP6ImwoO
bioclinica (16 hours ago)
RT @bioclinica: #Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most pressin…
bioclinica (17 hours ago)
RT @Xtalks: Trends in #Pharmacovigilance – Market Research and Future Impact This webinar will discuss an overview of key findings within r…
bioclinica (17 hours ago)
RT @IntClinTrials: Patient loss and can reduced by introducing new methods during the follow-up period. Martin Collyer at @bioclinica tells…
bioclinica (17 hours ago)
@bioclinica experts talk candidly about #Alzheimer's research & where improvements can be made. Joyce Suhy, Marieke… https://t.co/u1Wmu41jRr
bioclinica (17 hours ago)
RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen